Whether it’s collaborating on research for new medicines or learning about the latest treatment options, interactions between physicians and biopharmaceutical professionals lead to better health and better medicine. Congress added the “Sunshine” provisions to the Affordable Care Act, which will increase transparency when a new public database will outline the specifics of these interactions.